Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NIHR Journals Library
2010-10-01
|
| Series: | Health Technology Assessment |
| Online Access: | https://doi.org/10.3310/hta14suppl2/03 |
| _version_ | 1818272210469519360 |
|---|---|
| author | J Dretzke P Barton B Kaambwa M Connock O Uthman S Bayliss C Meads |
| author_facet | J Dretzke P Barton B Kaambwa M Connock O Uthman S Bayliss C Meads |
| author_sort | J Dretzke |
| collection | DOAJ |
| first_indexed | 2024-12-12T21:38:27Z |
| format | Article |
| id | doaj.art-c0d1ffcb96ed4c74907cab7a4c0a5f44 |
| institution | Directory Open Access Journal |
| issn | 1366-5278 2046-4924 |
| language | English |
| last_indexed | 2024-12-12T21:38:27Z |
| publishDate | 2010-10-01 |
| publisher | NIHR Journals Library |
| record_format | Article |
| series | Health Technology Assessment |
| spelling | doaj.art-c0d1ffcb96ed4c74907cab7a4c0a5f442022-12-22T00:11:08ZengNIHR Journals LibraryHealth Technology Assessment1366-52782046-49242010-10-0114Suppl 210.3310/hta14suppl2/0308/94/01Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemiaJ Dretzke0P Barton1B Kaambwa2M Connock3O Uthman4S Bayliss5C Meads6Unit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UKUnit of Health Economics, University of Birmingham, Birmingham, UKUnit of Health Economics, University of Birmingham, Birmingham, UKUnit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UKUnit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UKUnit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UKUnit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UKhttps://doi.org/10.3310/hta14suppl2/03 |
| spellingShingle | J Dretzke P Barton B Kaambwa M Connock O Uthman S Bayliss C Meads Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia Health Technology Assessment |
| title | Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia |
| title_full | Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia |
| title_fullStr | Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia |
| title_full_unstemmed | Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia |
| title_short | Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia |
| title_sort | rituximab for the treatment of relapsed refractory chronic lymphocytic leukaemia |
| url | https://doi.org/10.3310/hta14suppl2/03 |
| work_keys_str_mv | AT jdretzke rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia AT pbarton rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia AT bkaambwa rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia AT mconnock rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia AT outhman rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia AT sbayliss rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia AT cmeads rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia |